ASeq Newsletter

Share this post
First thoughts on PacBio and Omniome
aseq.substack.com

First thoughts on PacBio and Omniome

Nava Whiteford
Jul 22, 2021
Share this post
First thoughts on PacBio and Omniome
aseq.substack.com

PacBio appear to be set to acquire Omniome for $600 million with an additional $200 million in milestone payments. Similar to Illumina’s proposed acquisition of PacBio, the idea is that PacBio will be able to provide low error rate short reads at high throughput, along side their existing higher error rate long reads at low throughput.

In this post I wan…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2022 Nava Whiteford
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing